Neurocrine Biosciences Inc. said Joseph Mollica plans to retire as a director of the company, effective Oct. 17.
Neurocrine Biosciences director to retire
S&P Capital IQ Pro | Powering Your Edge
S&P Capital IQ Pro | Unrivaled Sector Coverage
Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud
Investment Research Analysts Providing Greater Coverage on Inflation